Ritter Daniher Financial Advisory’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.3K Hold
224
﹤0.01% 369
2026
Q1
$20.3K Hold
224
﹤0.01% 361
2025
Q4
$20.1K Hold
224
﹤0.01% 362
2025
Q3
$22.1K Hold
224
﹤0.01% 280
2025
Q2
$20.4K Hold
224
0.01% 225
2025
Q1
$25.4K Hold
224
0.01% 205
2024
Q4
$23.7K Hold
224
0.01% 201
2024
Q3
$24.2K Hold
224
0.01% 199
2024
Q2
$24.3K Hold
224
0.01% 190
2024
Q1
$29.6K Hold
224
0.01% 182
2023
Q4
$27.3K Hold
224
0.01% 182
2023
Q3
$25.1K Hold
224
0.01% 175
2023
Q2
$32.6K Hold
224
0.01% 159
2023
Q1
$28.9K Hold
224
0.01% 162
2022
Q4
$28.6K Hold
224
0.01% 172
2022
Q3
$23K Hold
224
0.02% 146
2022
Q2
$24K Hold
224
0.02% 137
2022
Q1
$29K Sell
224
-7
-3% -$844 0.02% 130
2021
Q4
$28K Hold
231
0.02% 131
2021
Q3
$33K Hold
231
0.02% 127
2021
Q2
$36K Hold
231
0.03% 115
2021
Q1
$36K Hold
231
0.03% 104
2020
Q4
$35K Buy
+231
New +$32.6K 0.03% 102

Other funds holding ZBH

Ritter Daniher Financial Advisory's ZBH Position: Q2 2026 in Review

Ritter Daniher Financial Advisory held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 224 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #369.

Ritter Daniher Financial Advisory first reported a position in ZBH in Q4 2020 and has held it in 23 quarters since. The position peaked at $36K in Q2 2021. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Ritter Daniher Financial Advisory held 224 shares of Zimmer Biomet worth $19.3K as of Q2 2026.
  • Ritter Daniher Financial Advisory left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up ﹤0.01% of Ritter Daniher Financial Advisory's portfolio in Q2 2026, its #369 holding.
  • Ritter Daniher Financial Advisory first reported a position in Zimmer Biomet in Q4 2020 and has held it in 23 quarters since.
  • Ritter Daniher Financial Advisory's Zimmer Biomet position peaked at $36K in Q2 2021.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Ritter Daniher Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.